Literature DB >> 10341269

GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning.

G E Stutzmann1, J E LeDoux.   

Abstract

Neurons in the lateral amygdala (LA) receive glutamatergic sensory input from the auditory thalamus and auditory cortex, and these inputs can be modulated by serotonin (5-HT). In the present study, we examined whether serotonergic inhibition of glutamatatergic excitation in the LA occurs via activation of GABAergic interneurons. Single-unit extracellular activity in the LA was recorded in response to iontophoretically applied glutamate. Concurrent application of 5-HT reduced the number of glutamate-evoked action potentials in the majority of neurons tested. GABA antagonists were then iontophoresed with both glutamate and 5-HT. Of the neurons that were inhibited by 5-HT, concurrent application of the GABA antagonists significantly reversed this effect. Application of the GABA antagonists alone had little or no effect on basal neuronal activity. We conclude that the 5-HT-induced inhibition of glutamatergic activity occurs in part through activation of serotonergic receptors on GABAergic interneurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341269      PMCID: PMC6782604     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety.

Authors:  Soyong Jang; Donghyun Kim; Yeonju Lee; Sohyeon Moon; Seikwan Oh
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

2.  Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala.

Authors:  A J McDonald; F Mascagni
Journal:  Neuroscience       Date:  2007-02-28       Impact factor: 3.590

3.  Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear conditioning and long-term potentiation.

Authors:  Stephanie C Lazzaro; Mian Hou; Catarina Cunha; Joseph E LeDoux; Christopher K Cain
Journal:  Learn Mem       Date:  2010-09-24       Impact factor: 2.460

Review 4.  Maternal programming of defensive responses through sustained effects on gene expression.

Authors:  Josie Diorio; Michael J Meaney
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

5.  Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders.

Authors:  Howard O'Rourke; Julie L Fudge
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

6.  The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning.

Authors:  Chin-Hsing Lin; Stacey Hansen; Zhenshan Wang; Daniel R Storm; Stephen J Tapscott; James M Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

7.  Enduring good memories of infant trauma: rescue of adult neurobehavioral deficits via amygdala serotonin and corticosterone interaction.

Authors:  Millie Rincón-Cortés; Gordon A Barr; Anne Marie Mouly; Kiseko Shionoya; Bestina S Nuñez; Regina M Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

Review 8.  Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.

Authors:  Esther Asan; Maria Steinke; Klaus-Peter Lesch
Journal:  Histochem Cell Biol       Date:  2013-03-15       Impact factor: 4.304

9.  Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.

Authors:  E Oral; H Ozcan; T S Kirkan; S Askin; M Gulec; N Aydin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-02       Impact factor: 5.270

10.  Effect of a single dose of citalopram on amygdala response to emotional faces.

Authors:  Susannah E Murphy; Raymond Norbury; Ursula O'Sullivan; Philip J Cowen; Catherine J Harmer
Journal:  Br J Psychiatry       Date:  2009-06       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.